By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
Gilead (GILD) Announces Results From Studies Evaluating Sofosbuvir-Based Regimens In Chronic Hepatitis C Patients With Genotypes 2-5 4/27/2015 11:06:35 AM
Merck & Co. (MRK) Poised To Enter Oral HCV Market Dominated by Gilead (GILD) and AbbVie (ABBV) 4/24/2015 6:22:34 AM
Gilead (GILD) To Release First Quarter 2015 Financial Results On Thursday, April 30, 2015 4/23/2015 7:49:11 PM
Gilead (GILD)’s Hepatitis C Combo Shows Cure Rate of 93% At Six Weeks, Fails at Four 4/23/2015 11:26:24 AM
Gilead (GILD)’s Harvoni And Sovaldi Demonstrate Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease 4/23/2015 6:28:11 AM
Gilead (GILD) Offers Free Drugs in Georgia in Hep C Eradication Experiment 4/23/2015 6:20:21 AM
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/21/2015 11:13:47 AM
Three Biotechs Well-Positioned for M&A: Gilead (GILD), Celgene (CELG), and Biogen (BIIB) 4/14/2015 6:16:45 AM
Will AbbVie (ABBV)'s HCV Candidates Threaten Gilead (GILD)? 4/9/2015 5:33:49 AM
Gilead (GILD) Submits New Drug Application To U.S.FDA For Fixed-Dose Combination Of Emtricitabine/Tenofovir Alafenamide For HIV Treatment 4/8/2015 11:36:04 AM